oligofructose-enriched inulin
Small moleculeexperimental
Clinical trial activity
4 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2006 (NCT00335504)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- oligofructose-enriched inulin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04949607 | N/A | Jul 1, 2021 | Centre for Neuro Skills, University of Texas, Galveston |
| NCT04194255 | N/A | Mar 31, 2020 | Swiss Federal Institute of Technology |
| NCT03653481 | N/A | Oct 31, 2018 | Beneo GmbH, University of Pennsylvania |
| NCT00335504 | Phase 2 | Mar 1, 2006 | Mayo Clinic, National Cancer Institute (NCI) |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Beneo GmbH | For profit | 1 | 0 | 1 | 2018 |
| Centre for Neuro Skills | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Mayo Clinic | Academic/Hospital | 1 | 0 | 1 | 2006 |
| National Cancer Institute (NCI) | Government | 1 | 1 | 1 | 2006 |
| Swiss Federal Institute of Technology | Academic/Hospital | 1 | 1 | 1 | 2020 |
| University of Pennsylvania | Academic/Hospital | 1 | 1 | 1 | 2018 |
| University of Texas, Galveston | Academic/Hospital | 1 | 0 | 1 | 2021 |
7 organizations
Page 1 / 1